Sonus Pharmaceuticals, Inc. Reviews Key Achievements in 2006 and Reports Fourth Quarter and Full Year Financial Results

BOTHELL, Wash.--(BUSINESS WIRE)--Sonus Pharmaceuticals, Inc., an oncology drug development company, (NASDAQ:SNUS) today highlighted its 2006 progress and reported financial results for the fourth quarter and year ended December 31, 2006.